INDEX 51 ▼2 todaySPLIT OF THE DAY NTT Data in final talks to build Anthropic's first Japan data center58 STORIES · 280 REACTIONSANTI-AI 63% · PRO-AI 20% · MIDDLE GROUND 18%LATEST NVIDIA highlights France's agentic AI deployments across multiple sectors
7 sources0 reactions

Palantir CTO says some AI researchers started smoking expecting cancer cure

48Story toneExecutive warning, framed as critique of AI extremism
7 sources · Yahoo Finance · www.ababnews.com · BigGo Finance
  • Doom: Sankar warned that both AI optimism and pessimism extremes reflect "social delusion"
  • Doom: Palantir CTO Shyam Sankar said some AI researchers started smoking expecting AI to cure cancer
  • Neutral: Remarks were reported by multiple outlets including Business Insider and Yahoo Finance on October 12, 2026
The story in full

Palantir CTO Shyam Sankar made public remarks stating that some AI researchers have taken up smoking because they believe AI will cure cancer, citing this as evidence of extreme optimism in the field. The comments were reported across multiple outlets on October 12, 2026.

Sankar framed both extreme optimism and extreme pessimism about AI as forms of what he called "social delusion." The smoking anecdote was used to illustrate how confident some researchers have become in AI's medical potential, to the point of altering personal health behavior based on that belief.

Analysis

407 words

On October 12, 2026, remarks by Palantir CTO Shyam Sankar drew attention after he claimed that some AI researchers have taken up smoking on the expectation that artificial intelligence will eventually cure cancer. Sankar used the anecdote as an illustration of what he described as extreme optimism inside the field, framing it as a behavioral bet on AI's medical capabilities. He placed this alongside extreme pessimism, calling both ends of the spectrum forms of "social delusion." The remarks were reported by outlets including Business Insider, Benzinga, and Yahoo Finance.

The significance of Sankar's comments lies less in the smoking anecdote itself and more in what it suggests about the cultural mood among some AI researchers. If taken at face value, it implies that confidence in AI-driven medical breakthroughs has moved beyond professional enthusiasm into something that shapes personal risk decisions. Sankar's choice to criticize both poles of AI sentiment is also notable given his employer. Palantir is a major commercial beneficiary of AI adoption, so a senior executive cautioning against uncritical optimism carries a different weight than the same argument made by an outside critic. What remains genuinely in dispute is whether the smoking claim reflects a real and meaningful pattern or is a rhetorical flourish, and whether Sankar's framing of symmetrical delusion is itself a balanced position or a way of softening a critique of hype.

None of the three camps had published reactions at the time of this report, so what follows reflects what each would typically argue in a story of this kind. Pro-AI voices would likely defend the underlying logic, arguing that if AI timelines for medical breakthroughs are credible, recalibrating personal risk behavior in response is rational rather than delusional. Anti-AI voices would probably treat the anecdote as confirmation that AI hype has reached a dangerous and absurd extreme, one that is now influencing real-world behavior in harmful ways. The middle ground camp would most likely agree with Sankar's framing, seeing the smoking story as a cautionary example of how both overcorrection and undercorrection distort reasonable assessment of what AI can realistically deliver.

The argument would sharpen considerably if Sankar or another Palantir figure elaborated on the claim with more specifics, or if researchers who fit the description chose to respond publicly. Any credible evidence from oncology or clinical AI research over the next year showing either a breakthrough or a plateau would also reframe how the anecdote is read in retrospect.

Where do you stand?

Add your take

0 reader votes

Sign in with Google to pick a side and post. Your vote moves the story's Doom / Boom score.

Sources

7 articles from 7 outlets
  1. Yahoo FinancePalantir CTO Says Some AI Researchers Are So Sure It Will Cure Cancer They’ve Started 'Smoking' — Warns Both AI Extremes Reflect ‘Social Delusion’
  2. www.ababnews.comPalantir CTO Shyam Sankar: Some AI Researchers Start Smoking to Prove Their Belief in AI Curing Cancer
  3. BigGo FinancePalantir CTO Says Some AI Researchers Took Up Smoking to Bet on Cancer Cure
  4. BenzingaPalantir CTO Says Some AI Researchers Are So Sure It Will Cure Cancer They’ve Started 'Smoking' — Warns B
  5. Business InsiderPalantir CTO says some AI researchers are taking up smoking because they expect AI to cure cancer
  6. India TodayPalantir CTO Shyam Sankar says researchers have started smoking, believing AI will cure cancer
  7. International Business Times, Singapore Edition'AI Researchers Have Started Smoking': Palantir CTO Says They Believe AI Will Cure Cancer